The HASP program is a twenty-month educational experience designed for house officers interested in pursuing healthcare administration as part of their careers. [ ... ]
Please Welcome our new Pathology Residents! They are a great addition to our already outstanding classes and some may even look familiar from M4 rotations and interviews last year!
Kristina Martin, MLS(ASCP)CH will present Document Control for Control Freaks during the Biomedical Laboratory Diagnostics (BLD) Seminar Series at Michigan State University. The series, celebrating its 90th year, invites BLD alumni to share educational lab topics and insights from their careers in health care. Kristina’s presentation is on Tuesday, February 28 at 4:00pm EST in North Kedzie Hall, room N317.
Assistant Professor of Forensic Pathology and Director of the Residency Training Program, Allecia Wilson, MD has been named President of the Michigan Association of Medical Examiners (MAME). MAME's mission is to foster the highest professional standards in the performance of the duties of the county medical examiners of Michigan. [ ... ]
The laboratory of Dr. Celina Kleer, Harold A. Oberman Collegiate Professor, isolated human mesenchymal stem cells from breast cancer metastasis. The lab discovered that a collagen receptor tyrosine kinase, DDR2, mediates stromal-cancer communication and induces breast cancer metastasis. The study provides the basis for the development of DDR2 inhibitors. The article appeared in Cell Reports and can be found at www.cell.com.
Effective December 20, 2016
The manufacturer of the chemistry analyzers and reagents used here at UMHS (Siemens Healthineers, Tarrytown NY) has recently announced a change in its calibration material for the direct bilirubin assay in order to bring results more in line with a reference method. [ ... ]
Kudos to Chemical Pathology’s Nick Wesener, MLS (ASCP)cm, Senior Clinical IT, POC for being selected to serve on the Alere Informatics RALS Advisory Board (RAB). The purpose of the RAB is to facilitate transparent discussion between Alere Informatics and the point-of-care testing community. Topics include issues and trends that may influence the way RALS Point-of-Care Data Management Systems programs are managed. Those selected to serve on this board are considered leaders in the field of point-of-care testing who can provide valuable feedback to Alere Informatics and experience and knowledge to other RALS users.
Laura Lamps, MD will join the Department of Pathology as the Director of Gastrointestinal Pathology on February 1. Dr. Lamps comes from the University of Arkansas for Medical Sciences Center where she was the Director of Surgical Pathology, Director of the Diagnostic Laboratories, and Professor and Vice Chair of Academic Affairs for Pathology. [ ... ]
The laboratory of Dr. Tomasz Cierpicki has determined the structure of BMI1 protein in complex with PHC2 and characterized its role in regulation of the architecture and activity of the PRC1. The article "BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization" has been published in Nature Communications. Co-first authors are Felicia Gray, Hyo-Je Cho and Shirish Shukla, and this is a collaborative study with Dr. Grembecka and Dr. Lawlor from the Department of Pathology.
Effective immediately, Dr. Allecia Wilson is the Program Director for the Anatomic and Clinical Pathology Residency Program. Dr. Wilson completed residency here at Michigan, followed by Forensic Pathology and later Pediatric Pathology fellowships. Since returning to our Department in 2012, Dr. Wilson has been recognized as a talented and devoted teacher of residents, fellows, and medical students. [ ... ]
Congratulations to Eric R. Fearon, MD, PhD, who has been named director of University of Michigan Comprehensive Cancer Center. Dr. Fearon's research focuses on the field of cancer genetics, specifically colorectal tumors. He has authored more than 135 peer-reviewed research manuscripts and more than 60 book chapters and review articles. [ ... ]
Clinical Pathology Operations Manager Kristina Martin, MS, MLS(ASCP)CM, is among one of twelve in the 2016 American Society for Clinical Laboratory Science (ASCLS) Voices Under 40 Spotlight. Awardees are scored by their peers and ranked according to their commitment to the ASCLS, their profession, and their communities early on in their professional careers. Congratulations, Kristina!
Dr. Thomas Giordano, M.D., Ph.D, the Henry Clay Bryant Professor of Pathology, led an international study on the genomics of adrenal cancer. The project was one of the 33 projects that comprise The Cancer Genome Atlas (TCGA) project of the NCI and NHGRI. The study results were published in Cancer Cell.
Dr. Ulysses Balis, M.D., Director of Pathology Informatics, was recently quoted in CAP Todays' Newsbytes. In the April 2016 news post, Dr. Balis advises on finding, fixing, and foiling shadow IT problems based on his experience here at UMHS.
View the full article online.
The laboratory of Dr. Yali Dou, Ph.D., Associate Professor of Pathology, reported new findings in the article “PRDM16 suppresses MLL1r leukemia via intrinsic histone methyltransferase activity” which was published in the journal Molecular Cell on April 27th, 2016. Dr. Bo Zhou is the first author. Other co-authors from the Department include Shirley Y. Lee, Yuqing Sun, and Rajesh C. Rao. The article can be found online at:
Assistant Professor, Sriram Venneti, MD, PhD, was named a Kimmel Scholar by the Sidney Kimmel Foundation. The Kimmel Scholar Awards are given annually to 15 innovative research scientists and medical doctors in the U.S. who are in the early stages of their careers. Dr. Venneti will receive a $200,000 grant for his work, titled, “Metabolic regulation of epigenetics in childhood brain tumors.” Congratulations, Dr. Venneti, on being recognized as one of the country’s most promising young cancer researchers!
Dr. David Lombard was inducted into the American Society for Clinical Investigation (ASCI).
The ASCI is an honor society of physician-scientists, those who translate findings in the laboratory to the advancement of clinical practice. Founded in 1908, the Society is home to nearly 3,000 members who are leaders in academic medicine and industry. Dr. Lombard was one of only 74 new members inducted at the annual ASCI meeting on April 15th.
Dr. Scott Owens, Associate Professor, has been selected by the Galens Medical Society to receive the 2016 Elizabeth Crosby Award, presented to a faculty member in the Medical School for outstanding teaching of medical students.
Dr. Dafydd Thomas is an author of the paper, Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas, which was featured on the December 2015 cover of the Journal of Clinical and Translational Research.
Click Here to view the article.
April 24-30, 2016Medical Laboratory Professionals Week (MLPW) originated in 1975 in an effort to raise public understanding and appreciation for the impact of the laboratory as it relates to a patient’s diagnosis and care. It is also critical for the public to understand the quality and professional accountability the lab has as it relates to the patient. Laboratorians play a vital role as a member of the health care team. This is also a moment for lab staff to recognize their contributions to patient care while having fun with their coworkers.
Congratulations to Dr. Asma Nusrat, Director of Experimental Pathology on her election as Vice President of the American Society for Investigative Pathology (ASIP). Her term is effective July 1, 2016 after which she will become President elect, then President on July 1, 2018. Dr. Nusrat has been a productive member of the ASIP community for over a decade participating in many program committees and task forces. Her commitment to enhance experimental pathology and translational medicine is admirable as evidenced by her work as the program committee chair for ASIP and PISA (Pathobiology for Investigators, Students, and Academicians) conference. Please join us in congratulating her on this prestigious national leadership appointment in Experimental Pathology
Description: The Department of Pathology invites applications from faculty with primary appointment in Pathology for proteomics related Pilot Projects that intend to use the state-of-the-art Proteomics Resource Facility (PRF) at the University of Michigan Medical School that is led by Dr. Alexey Nesvizhskii. Funds are primarily meant to help offset the cost of proteomic experiments, the results of which could potentially form the basis for or strengthen an extramural grant application. The grant is a cost share (2/3 funded by Department of Pathology and 1/3 by the investigator).
Who Can Apply: Department of Pathology Faculty
Applications will be accepted on a rolling basis and reviewed on a monthly basis. Applications received by Monday February 29, 2016 will be reviewed by March 8, 2016.
More information about this opportunity can be found by Clicking Here
Lauren Smith was named a UMHS Hospital Ethicist effective January 1, 2016. In this role, she serves as one of eight Ethicists funded through the Office of Clinical Affairs. The Ethicists are responsible for fielding ethics consults for adult and pediatric services and conducting educational sessions for the hospital. Lauren has served on the Adult Ethics Committee since 2005 and has been the Director of the University of Michigan Medical School Path of Excellence in Ethics since 2013.
Congratulations to Dr. Lauren B. Smith who has been appointed as the new Director of Hematopathology beginning on January 1, 2016. For the past 8 months, Dr. Smith has delivered outstanding service as the Acting Director of the Section of Hematopathology and Acting Director of the General Hematology Laboratory in addition to her full time roles as Director of the Hematopathology Fellowship, Director of the Ethics Path of Excellence at the University of Michigan Medical School, Laboratory Director at Forest Health Hospital and Laboratory Director at the University of Michigan Student Health Service . . .
The Board of Regents approved the design for the U-M Hospitals and Health Centers Clinical Pathology Laboratories Relocation and Renovation project. Approximately 186,000 gross square feet of space will be renovated within North Campus Research Complex Buildings 30, 35, 36 and 60, as well as University Hospital and University Hospital South to enhance the clinical lab functions necessary to meet present and future growth in test volumes, improve operational efficiency, and reduce the expense from having labs in their current locations. Hospitals and Health Centers' resources are funding the $160 million project that is scheduled to be completed in the summer of 2019.
View full news article via The University Record
It is my pleasure to announce Dr. Jonathan McHugh as the new Director of Surgical Pathology beginning on December 15, 2015. With expertise in head and neck pathology, Dr. McHugh brings outstanding diagnostic skills, extensive academic accomplishments and credentials, and top-rate organizational and teaching skills to this position. Originally from the Midwest, he did his undergraduate and graduate studies at University of Missouri in Columbia and . . .
It is with great pleasure that the Department of Pathology announces that Dr. David Lucas will become the Director of the Division of Anatomic Pathology. With expertise in bone and soft tissue pathology, Dr. Lucas brings outstanding clinical diagnostic skills, extensive academic accomplishments and credentials, and love of teaching to this new position.